2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$17.55-$0.08 (-0.48%)
Price as of Aug 21, 2026 7:48 PM EDT- $6.2BMarket Cap
- 1,001.88%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$17.55-$0.08 (-0.48%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.63 | ||
Change | +$0.55 (+3.22%) | ||
Open | $17.28 | ||
High | $17.84 | ||
Low | $17.21 | ||
Previous Close | $17.08 | ||
Volume | 2,445,434 | ||
30-Day Average Volume | 3,122,583 | ||
1-Week Change | -4.08% | ||
1-Month Change | -9.03% | ||
1-Year Change | 1,001.88% | ||
3-Year Change | 570.34% | ||
5-Year Change | -15.93% | ||
Fundamentals | |||
Shares Outstanding | 349.8M | ||
Total Assets | $435.1M | ||
Market Cap | $6.2B | ||
Enterprise Value | $6.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$44.1M | ||
Free Cash Flow | -$27.3M | ||
EBIT | -$44.1M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $244.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -141 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 17 | ||
P/E | -126 | ||
PEG | -2 | ||
Price/Free Cash Flow | -226 | ||
Price/Operating Cash Flow | -226 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue